{"id":54784,"date":"2023-03-13T22:04:33","date_gmt":"2023-03-13T21:04:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/"},"modified":"2023-03-13T22:04:33","modified_gmt":"2023-03-13T21:04:33","slug":"exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/","title":{"rendered":"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit"},"content":{"rendered":"
\n

\n– Presentation to be webcast on <\/i>www.exelixis.com<\/i><\/a> –<\/i>\n<\/p>\n

ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will provide a corporate overview at the 2023 Guggenheim Healthy Altitudes Summit on Thursday, March 16, 2023 at 10:00 a.m. ET \/ 8:00 a.m. MT \/ 7:00 a.m. PT.\n<\/p>\n

<\/a><\/p>\n

\nTo access the webcast link, log onto www.exelixis.com<\/a> and proceed to the News & Events \/ Event Calendar page under the Investors & Media heading. Please connect to the company\u2019s website at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to listen to the webcast. A replay will also be available at the same location for at least 30 days.\n<\/p>\n

\nAbout Exelixis<\/b>\n<\/p>\n

\nExelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by bi-coastal centers of discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX\u00ae (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com<\/a>, follow @ExelixisInc<\/a> on Twitter, like Exelixis, Inc.<\/a> on Facebook and follow Exelixis<\/a> on LinkedIn.\n<\/p>\n

\nExelixis, the Exelixis logo and CABOMETYX are registered U.S. trademarks.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors Contact:<\/b>
Varant Shirvanian<\/i>
Associate Director, Investor Relations<\/i>
Exelixis, Inc.<\/i>
650-837-7917<\/i>
vshirvanian@exelixis.com<\/i><\/a>\n<\/p>\n

\nMedia Contact:<\/b>
Hal Mackins<\/i>
For Exelixis, Inc.<\/i>
415-994-0040<\/i>
hal@torchcommunications.com<\/i><\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will provide a corporate overview at the 2023 Guggenheim Healthy Altitudes Summit on Thursday, March 16, 2023 at 10:00 a.m. ET \/ 8:00 a.m. MT \/ 7:00 a.m. PT. To access the webcast link, log onto … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54784","6":"format-standard","7":"category-industry"},"yoast_head":"\nExelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will provide a corporate overview at the 2023 Guggenheim Healthy Altitudes Summit on Thursday, March 16, 2023 at 10:00 a.m. ET \/ 8:00 a.m. MT \/ 7:00 a.m. PT. To access the webcast link, log onto ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-13T21:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230313005670\/en\/1679909\/21\/Exelixis_Logo_RGB_2023.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit\",\"datePublished\":\"2023-03-13T21:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/\"},\"wordCount\":313,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005670\\\/en\\\/1679909\\\/21\\\/Exelixis_Logo_RGB_2023.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/\",\"name\":\"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005670\\\/en\\\/1679909\\\/21\\\/Exelixis_Logo_RGB_2023.jpg\",\"datePublished\":\"2023-03-13T21:04:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005670\\\/en\\\/1679909\\\/21\\\/Exelixis_Logo_RGB_2023.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230313005670\\\/en\\\/1679909\\\/21\\\/Exelixis_Logo_RGB_2023.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/","og_locale":"en_US","og_type":"article","og_title":"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit - Pharma Trend","og_description":"– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will provide a corporate overview at the 2023 Guggenheim Healthy Altitudes Summit on Thursday, March 16, 2023 at 10:00 a.m. ET \/ 8:00 a.m. MT \/ 7:00 a.m. PT. To access the webcast link, log onto ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-13T21:04:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230313005670\/en\/1679909\/21\/Exelixis_Logo_RGB_2023.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit","datePublished":"2023-03-13T21:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/"},"wordCount":313,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230313005670\/en\/1679909\/21\/Exelixis_Logo_RGB_2023.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/","url":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/","name":"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230313005670\/en\/1679909\/21\/Exelixis_Logo_RGB_2023.jpg","datePublished":"2023-03-13T21:04:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230313005670\/en\/1679909\/21\/Exelixis_Logo_RGB_2023.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230313005670\/en\/1679909\/21\/Exelixis_Logo_RGB_2023.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/exelixis-to-webcast-fireside-chat-at-the-2023-guggenheim-healthy-altitudes-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54784"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54784\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}